UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000037275
Receipt No. R000042498
Scientific Title Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Date of disclosure of the study information 2019/07/05
Last modified on 2019/07/05 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Acronym Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Scientific Title Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Scientific Title:Acronym Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Region
Japan

Condition
Condition Rhegmatogenous retinal detachment
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Make selection standard for intraocular tamponade
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Final vision acuity
Key secondary outcomes Postoperative visual acuity , recurrence

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with rhegmatogenous retinal detachment treated at Yamagata University Hospital.
Patient who could get consent.
16 years old or older.
Key exclusion criteria Patient who has withdrawn consent.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Hidetoshi
Middle name
Last name Yamashita
Organization Yamagata University
Division name Ophthalmology
Zip code 990-9585
Address 2-2-2, Iida Nishi, Yamagata, Japan
TEL +81-23-628-5000
Email hyama-tky@umin.ac.jp

Public contact
Name of contact person
1st name Madoka
Middle name
Last name Nakamura
Organization Yamagata University
Division name Ophthalmology
Zip code 990-9585
Address 2-2-2, Iida Nishi, Yamagata, Japan
TEL +81-23-628-5000
Homepage URL
Email m-okochi@med.id.yamagata-u.ac.jp

Sponsor
Institute Yamagata University
Institute
Department

Funding Source
Organization Yamagata University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yamagata Univercity
Address 2-2-2, Iida Nishi, Yamagata, Japan
Tel +81-23-628-5000
Email m-okochi@med.id.yamagata-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 05 Month 17 Day
Date of IRB
Anticipated trial start date
2019 Year 07 Month 01 Day
Last follow-up date
2021 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Air selection standard
Within 2 weeks after onset
Not strong myopia
No history of cataract surgery complications
Not proliferative vitreoretinopathy grade C or higher

Management information
Registered date
2019 Year 07 Month 05 Day
Last modified on
2019 Year 07 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042498